OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

RyR2 and Calcium Release in Heart Failure
Jean‐Pierre Bénitah, Romain Perrier, Jean-Jacques Mercadier, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Recent advances in membrane mimetics for membrane protein research
John William Young
Biochemical Society Transactions (2023) Vol. 51, Iss. 3, pp. 1405-1416
Open Access | Times Cited: 27

Cardiac side effects of RNA‐based SARS‐CoV‐2 vaccines: Hidden cardiotoxic effects of mRNA‐1273 and BNT162b2 on ventricular myocyte function and structure
Rolf Schreckenberg, Nadine Woitasky, Nadja Itani, et al.
British Journal of Pharmacology (2023) Vol. 181, Iss. 3, pp. 345-361
Open Access | Times Cited: 14

Biophysical Modeling of Cardiac Cells: From Ion Channels to Tissue
Sergio Alonso, Enrique Álvarez-Lacalle, J. Bragard, et al.
Biophysica (2025) Vol. 5, Iss. 1, pp. 5-5
Open Access

Cannabidiol Prevents Heart Failure Dysfunction and Remodeling Through Preservation of Mitochondrial Function and Calcium Handling
Gerardo García‐Rivas, Omar Lozano, Judith Bernal‐Ramírez, et al.
JACC Basic to Translational Science (2025)
Open Access

Right ventricular dysfunction following surgical repair of tetralogy of Fallot: Molecular pathways and therapeutic prospects
Pingyi Fan, Yabo Wang, Qi An, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117924-117924
Closed Access

Genetic variation in RYR1 is associated with heart failure progression and mortality in a diverse patient population
Leonardo A. Guerra, Christelle Lteif, Yimei Huang, et al.
Frontiers in Cardiovascular Medicine (2025) Vol. 12
Open Access

Molecular, Subcellular, and Arrhythmogenic Mechanisms in Genetic RyR2 Disease
Ewan D. Fowler, Spyros Zissimopoulos
Biomolecules (2022) Vol. 12, Iss. 8, pp. 1030-1030
Open Access | Times Cited: 21

Gene Therapy With the N-Terminus of Junctophilin-2 Improves Heart Failure in Mice
Jinxi Wang, Qian Shi, Yihui Wang, et al.
Circulation Research (2022) Vol. 130, Iss. 9, pp. 1306-1317
Open Access | Times Cited: 16

Calreticulin and the Heart
Jody Groenendyk, Wen‐An Wang, Alison Robinson, et al.
Cells (2022) Vol. 11, Iss. 11, pp. 1722-1722
Open Access | Times Cited: 13

Targeting calcium-mediated inter-organellar crosstalk in cardiac diseases
Mohit Hulsurkar, Satadru K. Lahiri, Jason Karch, et al.
Expert Opinion on Therapeutic Targets (2022) Vol. 26, Iss. 4, pp. 303-317
Open Access | Times Cited: 10

Screening for Novel Type 2 Ryanodine Receptor Inhibitors by Endoplasmic Reticulum Ca2+Monitoring
Mai Takenaka, Masami Kodama, Takashi Murayama, et al.
Molecular Pharmacology (2023) Vol. 104, Iss. 6, pp. 275-286
Open Access | Times Cited: 5

Changes in cellular Ca2+ and Na+ regulation during the progression towards heart failure
Kenneth T. MacLeod
The Journal of Physiology (2022) Vol. 601, Iss. 5, pp. 905-921
Open Access | Times Cited: 8

Ion channel trafficking implications in heart failure
Jean‐Baptiste Reisqs, Yongxia Qu, Mohamed Boutjdir
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 1

A novel ryanodine receptor 2 inhibitor, M201‐A, enhances natriuresis, renal function and lusi‐inotropic actions: Preclinical and phase I study
Noboru Kaneko, Christopher M. Loughrey, Godfrey L. Smith, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 18, pp. 3401-3419
Open Access | Times Cited: 1

Changes of calcium cycling in HFrEF and HFpEF
Jian Shou, Yunlong Huo
Mechanobiology in Medicine (2023) Vol. 1, Iss. 1, pp. 100001-100001
Open Access | Times Cited: 4

Chronic catestatin treatment reduces atrial fibrillation susceptibility via improving calcium handling in post-infarction heart failure rats
Min Yan, Tao Liu, Peng Zhong, et al.
Peptides (2022) Vol. 159, pp. 170904-170904
Closed Access | Times Cited: 6

Role of ryanodine receptor 2 and FK506-binding protein 12.6 dissociation in pulmonary hypertension
Yong-Xiao Wang, Jorge Reyes-García, Annarita Di Mise, et al.
The Journal of General Physiology (2022) Vol. 155, Iss. 3
Open Access | Times Cited: 6

The Mechanism of the Anti-Cardiac Hypertrophy Effect of Glycyrrhizic Acid Is Related to Reducing STIM1-Dependent Store-Operated Calcium Entry
Xiaoling Cheng, Huang Li-juan
Bulletin of Experimental Biology and Medicine (2023) Vol. 174, Iss. 6, pp. 701-706
Closed Access | Times Cited: 3

The Role of Ranolazine in Heart Failure-Current Concepts
Islam Kourampi, Maria Katsioupa, Evangelos Oikonomou, et al.
The American Journal of Cardiology (2023) Vol. 209, pp. 92-103
Closed Access | Times Cited: 3

The ryanodine receptor microdomain in cardiomyocytes
Eef Dries, Guillaume Gilbert, H. Llewelyn Roderick, et al.
Cell Calcium (2023) Vol. 114, pp. 102769-102769
Open Access | Times Cited: 2

Effects of the angiotensin-converting enzyme inhibitor captopril on occlusal-disharmony-induced cardiac dysfunction in mice
Aiko Ito, Yoshiki Ohnuki, Kenji Suita, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 2

HIV-Tat Exacerbates the Actions of Atazanavir, Efavirenz, and Ritonavir on Cardiac Ryanodine Receptor (RyR2)
Fadhel A. Alomar, Chengju Tian, Sean R. Bidasee, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 274-274
Open Access | Times Cited: 4

Page 1 - Next Page

Scroll to top